Picture of Inhibikase Therapeutics logo

IKT Inhibikase Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Inhibikase Therapeutics Entered Into An At The Market Offering Agreement With H.C. Wainwright & Co As Sales Agent

Feb 1 (Reuters) - Inhibikase Therapeutics Inc  IKT.O :
    * INHIBIKASE THERAPEUTICS INC-  ENTERED INTO AN AT THE
MARKET
OFFERING AGREEMENT WITH H.C. WAINWRIGHT & CO., LLC, AS SALES
AGENT
    * INHIBIKASE THERAPEUTICS-PURSUANT TO DEAL, CO MAY ISSUE &
SELL
SHARES OF ITS COMMON STOCK IN AN AGGREGATE OFFERING PRICE OF UP
TO $5.66 MILLION

Source text for Eikon:  ID:n0001193125-24-021850 
Further company coverage:  IKT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Inhibikase Therapeutics

See all news